Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lantus
Biotech
Rejected by Lilly, Adocia mounts recovery with diabetes deal
The deal sparked a 30% jump in Adocia’s stock price as investors cheered evidence the biotech is gaining momentum after being dumped by Eli Lilly.
Nick Paul Taylor
Apr 26, 2018 9:16am
Voluntis adds Toujeo to basal insulin management app, with eyes on more
Jul 19, 2017 9:25am
Sanofi, Voluntis ally to pilot diabetes management app
Mar 15, 2017 5:12am
